High-risk prostate cancer treated with I-125 brachytherapy.

被引：0
|
作者：
Stockham, Abigail Lauren [1 ]
Reddy, Chandana A. [1 ]
Stephans, Kevin L. [1 ]
Ciezki, Jay P. [1 ]
Tendulkar, Rahul D. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.134
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
134
引用
收藏
页数：1
相关论文
共 50 条
  • [1] OUTCOME AFTER I-125 BRACHYTHERAPY COMBINED WITH EXTERNAL BEAM RADIOTHERAPY FOR HIGH-RISK PROSTATE CANCER
    Shiraishi, Y.
    Yorozu, A.
    Ohashi, T.
    Toya, K.
    Yoshida, K.
    Kaneda, T.
    Saito, S.
    Nishiyama, T.
    Hanada, T.
    Shigematsu, N.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S286 - S287
  • [2] The analysis of prostate cancer with median lobe hyperplasia treated I-125 brachytherapy
    Muraki, K.
    Suefuji, H.
    Ogo, E.
    Eto, H.
    Tsuji, C.
    Hattori, C.
    Miyata, Y.
    Himuro, H.
    Abe, T.
    Hayashi, S.
    Chikui, K.
    Nakiri, M.
    Igawa, T.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S97 - S98
  • [3] Biochemical outcomes for patients with intermediate risk prostate cancer treated with I-125 interstitial brachytherapy monotherapy
    Anna Thi Huyen Tran
    Mandall, Paula
    Swindell, Ric
    Hoskin, P. J.
    Bottomley, David Martin
    Logue, John Paul
    Wylie, James Pinson
    RADIOTHERAPY AND ONCOLOGY, 2013, 109 (02) : 235 - 240
  • [4] The Effect of Androgen Deprivation Therapy on Prostate Cancer-Specific Mortality in Patients With High-Risk Prostate Cancer Treated with I-125 Brachytherapy as the Sole Radiation Therapeutic Modality
    Ciezki, J. P.
    Reddy, C. A.
    Weller, M. A.
    Tendulkar, R. D.
    Stephans, K. L.
    Klein, E. A.
    Ulchaker, J.
    Angermeier, K.
    Campbell, S.
    Stephenson, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E223 - E223
  • [5] Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer
    Harada, Kosaku
    Ishikawa, Hitoshi
    Saito, Yoshitaka
    Nakamoto, Soken
    Kawamura, Hidemasa
    Wakatsuki, Masaru
    Etsunaga, Toru
    Takezawa, Yutaka
    Kobayashi, Mikio
    Nakano, Takashi
    JOURNAL OF RADIATION RESEARCH, 2012, 53 (06) : 923 - 929
  • [6] Targeted axillary lymph node dissection in breast cancer patients using I-125 microseeds for prostate cancer brachytherapy.
    Emelyanov, Alexander
    Petr, Krivorotko
    Pesotskiy, Roman
    Bessonov, Alexander
    Gorelov, Viktor
    Semiglazov, Vladimir
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] I-125 or Pd-103 for brachytherapy boost in men with high-risk prostate cancer: A comparison of survival and morbidity outcomes
    Stone, Nelson N.
    Skouteris, Vassilios M.
    Rosenstein, Barry S.
    Stock, Richard G.
    BRACHYTHERAPY, 2020, 19 (05) : 567 - 573
  • [8] The Risk of Second Malignancies after Seed Migration in Prostate Cancer Patients Treated With I-125 Free Seeds Brachytherapy
    Vigneault, E.
    Martell, K.
    Taussky, D.
    Husain, S. M.
    Delouya, G.
    Mbodji, K.
    Magnan, S.
    Despres, P.
    Lavallee, M. C.
    Aubin, S.
    Beaulieu, L.
    Foster, W.
    Martin, A. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E271 - E271
  • [9] Statistical analysis of I-125 prostate brachytherapy
    Jang, S.
    Pyakuryal, A.
    Sathiaseelan, V.
    Luo, J.
    Kalapurakal, J.
    MEDICAL PHYSICS, 2007, 34 (06) : 2490 - 2490
  • [10] Development of method to visualize I-125 seed in postimplant seed identification in prostate permanent implant brachytherapy.
    Takahashi, Y.
    Sumida, I.
    Kozuka, T.
    Ito, A.
    Yamashita, T.
    MEDICAL PHYSICS, 2006, 33 (06) : 2086 - 2086
12345